🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this pilot study is to determine the within-subjec...
Status
Completed
Location
PPD Phase 1 Unit
Start Date
2011-10
Trial ID
NCT01452542
Gaucher disease is a genetic disease that results in a deficiency of an enz...
Status
Completed
Location
New York University
Start Date
2006-06
Trial ID
NCT00358150
Treatments Being Tested
Primary Objective: Evaluated the safety and pharmacokinetics of eliglustat...
Status
Completed
Location
Investigational Site Number : 0320001
Start Date
2018-04-11
Trial ID
NCT03485677
Treatments Being Tested
The primary objective of this study was to evaluate the efficacy and safety...
Status
Completed
Location
University of California, San Diego Medical Center
Start Date
2010-06
Trial ID
NCT01074944
Treatments Being Tested
The primary objective of the study is to evaluate dose proportionality and ...
Status
Completed
Location
M.D.Covance Clinical Research Unit 1341 W
Start Date
2018-01-01
Trial ID
NCT06188325
Treatments Being Tested
Targeted therapy against the CD30 molecule has achieved some progress in CD...
Status
Recruiting
Location
People's Liberation Army General Hospital
Start Date
2025-12-26
Trial ID
NCT07138547
Treatments Being Tested
The primary objective of this study is to determine the effect of repeat or...
Status
Completed
Location
PPD Phase I Clinic
Start Date
2011-08
Trial ID
NCT01357811
Treatments Being Tested
The primary objective is to determine the effect of repeated oral doses of ...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01659944
Treatments Being Tested
In this single-center,open-label, randomized, phase II study, the efficacy ...
Status
Recruiting
Location
China
Start Date
2026-03-01
Trial ID
NCT06558773
Primary Objective: To study the effect of mild, moderate, and severe renal...
Status
Completed
Location
Investigational Site Number 840004
Start Date
2015-09
Trial ID
NCT02536937
Treatments Being Tested